Bivictrix Therapeutics Plc (BVX)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current BVX market cap is 8.25M. The company's latest EPS is GBP -0.0308 and P/E is -3.25.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 31k | 0 | 0 | 0 |
| Operating Income | -526k | -509k | -1.89M | -2.98M | -3.03M |
| Net Income | -409k | -425k | -2.34M | -2.5M | -2.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 266k | 1.07M | 6.88M | 4.54M | 4.3M |
| Total Liabilities | 86k | 1M | 554k | 579k | 758k |
| Total Equity | 180k | 67k | 6.33M | 3.96M | 3.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -357k | -166k | -1.79M | -2.4M | -1.96M |
| Investing | N/A | -63k | -46k | -379k | 17k |
| Financing | 275k | 962k | 7.03M | N/A | 1.94M |
| Market Cap | 8.25M |
| Price to Earnings Ratio | -3.25 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.52 |
| Price to Book Ratio | 2.33 |
| Dividend Yield | - |
| Shares Outstanding | 82.53M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -9.09% |
| 52 Week High | 13.00 |
| 52 Week Low | 7.50 |
| Spread (Intraday) | 1 (10.53%) |
| Company Name | Bivictrix Therapeutics Plc |
| Address |
c/o slater heelis limited manchester M3 2ER |
| Website | https://www.bivictrix.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
